What Princeton BioMolecular Research does

Princeton BioMolecular Research is a privately held chemistry tools and contract research company founded in 1998 and headquartered at 475 Wall Street, Princeton, New Jersey. The company designs unique small molecules and develops tools for drug discovery, with a portfolio spanning over 1.3 million screening compounds across more than 50 chemical classes, 105,000 organic building blocks and reagents, and specialized collections including PPI-focused BBs (3,000+ compounds), 3D-shaped BBs (453), kinase/GPCR-focused libraries, macrocycles, and fragment libraries. All compounds meet documented purity standards (90%+ for screening compounds, 95%+ for building blocks validated by NMR and LC-MS), with quarterly stock re-evaluation and delivery in 3-5 days from a single Princeton facility.

The company operates an integrated platform combining catalog-based compound and building-block sales with custom synthesis services (milligrams to multi-kilograms), computational chemistry services (virtual screening, QSAR, docking, scaffold hopping, homology modeling), tangible custom arrays, and FDA 21 CFR Part 11-compliant Active Pharmaceutical Ingredient manufacturing. Revenue is generated through unit-priced catalog sales via the princetonbio.com e-commerce platform, quote-based custom synthesis and FTE contract research engagements, and API supply with regulatory documentation. The horizontal go-to-market targets pharmaceutical and biotechnology companies (primary), crop science companies, and academic research institutions across North America.

Business operations reflect a 25+ year bootstrapped profile: privately held, no disclosed funding rounds, no parent company, no disclosed acquisitions, and a static 11-50 employee range. Distribution combines a self-serve online storefront (credit card payments, downloadable SDF database files for registered users) with direct enterprise sales for custom synthesis and API contracts. Contact channels include dedicated customer support ([email protected]), technical support (732-355-9920), and order/inquiry inboxes. No named customer logos, partnerships, management team details, or financial metrics are publicly disclosed.

Name

Princeton BioMolecular Research

Legal name

Princeton BioMolecular Research, Inc.

Website

https://princetonbio.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Drug Discovery Chemistry

NAICS

Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (3254), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731), Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Generic APIs & Intermediates (Active Ingredients) (HLAIABAG)

akta.pro secondary industry

Generic ANDA/Regulatory Affairs & Submissions (HLAIABAJ)

Keywords

• Drug discovery chemicals
• Screening compounds library
• Organic building blocks
• Custom synthesis services
• Computational chemistry

Headquarters

HQ city

Princeton

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D

Revenue model

1. Screening Compound Sales: Sale of screening compounds from stock library. Express Collection offers over 1.3M compounds with 90+% purity, delivered in 3-5 days. Compounds available in client's preferred format (vials, plates, dry form, or dissolved in DMSO).
2. Building Blocks Sales: Sale of organic building blocks from catalog. 105,000 reagents and scaffolds available in 24-hour shipping or synthesized on demand. Tangible Building Blocks available in multigram quantities within 3-6 weeks.
3. Focused Library Sales: Sale of focused library sets targeting Kinases, GPCRs, and specific biological targets. Sets of 300-1,000 compounds in 1mg to 5mg quantities, delivered in 2+ weeks.
4. Custom Synthesis & Contract Research: Custom synthesis services from milligrams to multi-kilograms. FTE agreements with weekly reports for ongoing projects. Includes metal-mediated reactions, reductions, hydrogenations, Grignard reactions, and multi-step syntheses.
5. Active Pharmaceutical Ingredients (API): Manufacturing and supply of active pharmaceutical ingredients with FDA-compliant documentation, regulatory compliance, storage, packaging, and quality control.
6. Computational Services: Computational chemistry services including cheminformatics, ligand-based and receptor-based virtual screening, QSAR modeling, and scaffold hopping for drug design projects.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels1 record

Core offering

Princeton BioMolecular Research manufactures and sells catalog chemical libraries (over 1.3 million screening compounds, 105,000 organic building blocks, focused and fragment libraries) and provides custom synthesis, computational chemistry, and FDA-compliant active pharmaceutical ingredient (API) manufacturing services to support pharmaceutical, biotech, crop science, and academic drug discovery programs.

Product overview

Princeton BioMolecular Research offers a comprehensive small molecule drug discovery platform consisting of screening compounds (Express Collection with 1.3M+ compounds), organic building blocks (105,000+ reagents), and focused libraries. The portfolio includes specialized collections for PPI inhibition (3,000+ BBs), 3D shape diversity (453 BBs), kinase and GPCR targeting, macrocycles, and fragments. Supporting services include custom synthesis (milligrams to multi-kilograms), computational chemistry (virtual screening, QSAR, scaffold hopping), tangible arrays, and FDA-compliant active pharmaceutical ingredients. All products are designed to support hit identification, lead optimization, and drug discovery workflows.

Differentiator

Problem solved

Functional benefit

Products and services

• Screening Compounds (Express Collection)

Quantifiable outcome

• 90+% purity maintained across screening compounds with quarterly stock re-evaluation
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Specs: Specs (Netherlands) supplies compound libraries, building blocks, and custom synthesis to pharma and academic customers in Europe and globally. Directly comparable product offerings with strong EU presence complementing Princeton's US-centric footprint.
• Enamine: Enamine is the world's largest provider of building blocks and screening compounds, with millions of in-stock reagents and extensive custom synthesis services. Directly comparable to Princeton BioMolecular Research's building blocks, screening library, and custom synthesis offerings, but at materially larger catalog and geographic scale.
• ChemBridge Corporation: ChemBridge supplies screening compound libraries, building blocks, and custom synthesis services to pharma and biotech customers globally. Directly comparable catalog products and customer base, with stronger commercial reach into US pharma hubs.
• MolPort: MolPort operates a marketplace aggregator for screening compounds and building blocks from multiple suppliers including Princeton-class vendors. Comparable through overlapping catalog content and global sourcing/distribution for pharma procurement.
• Combi-Blocks: Combi-Blocks supplies screening compounds and building blocks focused on medicinal chemistry applications. Directly competes with Princeton's screening library and reagent catalog, particularly for US-based biotech and academic customers.
• AstaTech: AstaTech provides building blocks, intermediates, and custom synthesis services focused on US pharma and biotech customers. Directly comparable in product mix and target customer base, with overlapping emphasis on novel scaffolds and medicinal chemistry reagents.
• ChemDiv: ChemDiv offers screening libraries, building blocks, custom synthesis, and integrated drug discovery services. Closely comparable product portfolio including targeted libraries and custom chemistry, with established presence in US and European markets.
• Life Chemicals: Life Chemicals provides screening libraries, building blocks, and custom synthesis with emphasis on focused/targeted libraries and computational chemistry support. Directly comparable product mix including sp3-enriched and focused collections.

Broad incumbents

• WuXi AppTec: WuXi AppTec operates a broad contract research, development, and manufacturing organization including custom synthesis and building block supply. Comparable through overlapping custom synthesis and API offerings, but at vastly larger scale and broader service portfolio.
• eMolecules: eMolecules operates a large chemical sourcing platform aggregating building blocks and screening compounds from hundreds of suppliers. Comparable through overlapping catalog content but operates as a marketplace rather than a primary manufacturer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Princeton BioMolecular Research